サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1713493

抗微生物ペプチドの世界市場レポート 2025年

Anti Microbial Peptides Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
抗微生物ペプチドの世界市場レポート 2025年
出版日: 2025年04月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗微生物ペプチド市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で96億3,000万米ドルに成長します。予測期間の成長は、ヘルスケアにおける需要の高まり、規制当局の承認、ペプチドベースの医薬品開発への投資の増加、抗菌剤耐性緩和への注目の高まり、ペプチド合成・デリバリー技術の進歩などに起因すると考えられます。予測期間の主な動向には、技術の進歩、革新的な治療法、バイオテクノロジー技術、研究開発、人工ペプチドの開発、バイオテクノロジーの進歩などがあります。

感染症の罹患率の上昇は、抗菌ペプチド市場の成長を促進すると予想されます。細菌、ウイルス、真菌、寄生虫などの有害な生物によって引き起こされる感染症は、気候変動、薬剤耐性病原体の出現、食生活の乱れなどの要因により増加しています。抗菌ペプチドは、こうした問題に対する有望な解決策であり、抗生物質耐性の課題や従来の治療の限界に対処する新たな治療選択肢を提供します。例えば、2023年10月、英国の公共部門情報サイトGov.ukによると、イングランドでは2022年に新たに3,805人のHIV感染者が診断され、2021年の3,118人から22％、2020年の3,026人から26％増加しました。この感染症の急増が抗菌ペプチド市場の成長を後押ししています。

抗菌ペプチド分野の主要企業は、生分解性抗菌ペプチドなどの最先端製品の開発に注力し、抗菌剤耐性への対応や治療効果の向上に取り組んでいます。生分解性抗菌ペプチドは、細菌、ウイルス、真菌などの有害な微生物を中和した後、無害な製品別に分解する短いタンパク質です。例えば、2024年9月、ドイツに本社を置くパーソナルケア製品メーカーのバイヤスドルフ社は、米国を拠点とする生物工学企業のマクロ・バイオロジクス社と提携し、このペプチドを開発しました。この提携は、革新的な生分解性抗菌ソリューションを生み出すことを目的としており、高度なバイオテクノロジー・イノベーションと持続可能性の目標を組み合わせるという化粧品業界の動向を反映しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界抗微生物ペプチド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の抗微生物ペプチド市場：成長率分析
  • 世界の抗微生物ペプチド市場の実績：規模と成長, 2019-2024
  • 世界の抗微生物ペプチド市場の予測：規模と成長, 2024-2029, 2034F
  • 世界抗微生物ペプチド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の抗微生物ペプチド市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 植物抗菌ペプチド
  • 細菌抗菌ペプチド
  • 動物抗菌ペプチド
  • 昆虫抗菌ペプチド
  • 世界の抗微生物ペプチド市場病気によって、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 肺炎
  • 肝炎
  • 細菌感染症
  • ヒト免疫不全ウイルス
  • 世界の抗微生物ペプチド市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • トピック
  • 皮下
  • 静脈内
  • 世界の抗微生物ペプチド市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 調査機関
  • 専門クリニック
  • 薬局
  • 世界の抗微生物ペプチド市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬・ヘルスケア
  • 農業産業
  • 生物工学
  • 世界の抗微生物ペプチド市場植物抗菌ペプチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • デフェンシン
  • チオニン
  • ヘベイン様ペプチド
  • 植物デフェンシン様ペプチド
  • 脂質輸送タンパク質（LTP）
  • 世界の抗微生物ペプチド市場細菌抗菌ペプチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バシトラシン
  • ナイシン
  • 雑誌
  • プロテグリン
  • バシロシン
  • 世界の抗微生物ペプチド市場動物抗菌ペプチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • カテリシジン
  • デフェンシン
  • ヒスタチン
  • ラクトフェリン
  • カチオン性抗菌ペプチド（CAMP）
  • 世界の抗微生物ペプチド市場昆虫抗菌ペプチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • セクロピン
  • デフェンシン
  • アタシンス
  • ジプテリシン
  • メリティン

第7章 地域別・国別分析

  • 世界の抗微生物ペプチド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の抗微生物ペプチド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 抗微生物ペプチド市場：競合情勢
  • 抗微生物ペプチド市場：企業プロファイル
    • Wuxi AppTec Overview, Products and Services, Strategy and Financial Analysis
    • Sigma Aldrich Chemicals Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Ipsen S.A. Overview, Products and Services, Strategy and Financial Analysis
    • Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
    • GenScript Biotech Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Bachem Holding AG
  • Basilea Pharmaceutica Ltd.
  • Probiotec Limited
  • Migenix Inc.
  • Zymeworks Inc.
  • Venatorx Pharmaceuticals Inc.
  • AMPS Biotech Pvt. Ltd.
  • AnaSpec Inc.
  • MediGene AG
  • Hycult Biotech
  • Phoenix Biotechnology Inc.
  • Shenzhen Sunsmile Biotechnology Co. Ltd.
  • WatsonBio Sciences
  • Helix BioMedix
  • Jiangsu ProteLight Pharmaceutical and Biotechnology Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 抗微生物ペプチド市場2029：新たな機会を提供する国
  • 抗微生物ペプチド市場2029：新たな機会を提供するセグメント
  • 抗微生物ペプチド市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33395

Antimicrobial peptides (AMPs) are short proteins that play a vital role in the immune system by defending against bacteria, viruses, fungi, and parasites. They function by disrupting the cell membranes of pathogens, leading to their destruction. AMPs are naturally produced by a wide range of organisms, including humans, animals, and plants, and are being investigated as potential alternatives to traditional antibiotics due to their broad-spectrum antimicrobial activity.

The main types of antimicrobial peptides include plant antimicrobial peptides, bacterial antimicrobial peptides, animal antimicrobial peptides, and insect antimicrobial peptides. Plant antimicrobial peptides are small proteins produced by plants to protect against pathogens such as bacteria, fungi, and viruses. These peptides can address various ailments including pneumonia, hepatitis, bacterial infections, and HIV. They can be administered through different routes, such as topical, subcutaneous, and intravenous. Antimicrobial peptides are distributed through various channels including hospitals, research institutes, specialty clinics, pharmacies, and are used by sectors such as pharmaceuticals and healthcare, agriculture, and biological engineering.

The antimicrobial peptides market research report is one of a series of new reports from The Business Research Company that provides antimicrobial peptides market statistics, including antimicrobial peptides industry global market size, regional shares, competitors with an antimicrobial peptides market share, detailed antimicrobial peptides market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial peptides industry. This antimicrobial peptides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti microbial peptides market size has grown strongly in recent years. It will grow from $6.49 billion in 2024 to $7.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the rising prevalence of antibiotic-resistant infections, increasing demand for novel antimicrobial therapies, growing concerns over the efficacy of traditional antibiotics, and expansion of research funding for antimicrobial drug discovery.

The anti microbial peptides market size is expected to see strong growth in the next few years. It will grow to $9.63 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand in healthcare, regulatory approvals, growing investment in peptide-based drug development, rising focus on antimicrobial resistance mitigation, and advancements in peptide synthesis and delivery technologies. Major trends in the forecast period include technological advancements, innovative therapeutics, biotechnology techniques, research and development, development of engineered peptides, and advancements in biotechnology.

The rising incidence of infectious diseases is anticipated to drive the growth of the antimicrobial peptide market. Infectious diseases, caused by harmful organisms such as bacteria, viruses, fungi, or parasites, are increasing due to factors such as climate change, the emergence of drug-resistant pathogens, and poor dietary habits. Antimicrobial peptides present a promising solution for these issues, offering new therapeutic options that address the challenges of antibiotic resistance and the limitations of traditional treatments. For example, in October 2023, the UK public sector information website Gov.uk reported that England saw 3,805 new HIV diagnoses in 2022, a 22% increase from the 3,118 cases in 2021 and a 26% rise from the 3,026 cases in 2020. This surge in infectious diseases is fueling the growth of the antimicrobial peptide market.

Leading companies in the antimicrobial peptide sector are focusing on developing cutting-edge products, such as biodegradable antimicrobial peptides, to tackle antimicrobial resistance and improve treatment effectiveness. Biodegradable antimicrobial peptides are short proteins that decompose into harmless byproducts after neutralizing harmful microorganisms such as bacteria, viruses, and fungi. For instance, in September 2024, Beiersdorf AG, a personal care product manufacturer based in Germany, teamed up with Macro Biologics, a US-based bioengineering firm, to develop these peptides. This partnership aims to create innovative biodegradable antimicrobial solutions, reflecting a trend in the cosmetics industry toward combining advanced biotechnological innovations with sustainability goals.

In December 2023, Invaio Sciences Inc., a US-based biotechnology firm, acquired Peptyde Bio Inc. for an undisclosed sum. This acquisition is intended to bolster Invaio Sciences' capabilities in precision agriculture through advanced peptide-based technologies. Peptyde Bio Inc., also based in the US, specializes in developing novel antimicrobial peptides.

Major companies operating in the anti microbial peptides market are Wuxi AppTec, Sigma Aldrich Chemicals Private Limited, Ipsen S.A., Novozymes A/S, GenScript Biotech, Bachem Holding AG, Basilea Pharmaceutica Ltd., Probiotec Limited, Migenix Inc., Zymeworks Inc., Venatorx Pharmaceuticals Inc., AMPS Biotech Pvt. Ltd., AnaSpec Inc., MediGene AG, Hycult Biotech, Phoenix Biotechnology Inc., Shenzhen Sunsmile Biotechnology Co. Ltd., WatsonBio Sciences, Helix BioMedix, Jiangsu ProteLight Pharmaceutical and Biotechnology Co Ltd.

North America was the largest region in the anti microbial Peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti microbial peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti microbial peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial peptides market consists of sales of natural antimicrobial peptides, synthetic antimicrobial peptides, modified antimicrobial peptides, antimicrobial peptide-based drugs, and antimicrobial peptide-based diagnostic kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti Microbial Peptides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti microbial peptides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti microbial peptides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti microbial peptides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Plant Antimicrobial Peptides; Bacterial Antimicrobial Peptides; Animal Antimicrobial Peptides; Insect Antimicrobial Peptides
  • 2) By Ailments: Pneumonia; Hepatitis; Bacterial infections; Human Immunodeficiency Viruses
  • 3) By Route of Administration: Topical; Subcutaneous; Intravenous
  • 4) By Distribution Channel: Hospital; Research Institutes; Specialty Clinic; Pharmacies
  • 5) By End-User: Pharma And Healthcare; Agriculture Industry; Biological Engineering
  • Subsegments:
  • 1) By Plant Antimicrobial Peptides: Defensins; Thionins; Hevein-Like Peptides; Plant Defensin-Like Peptides; Lipid Transfer Proteins (LTPs)
  • 2) By Bacterial Antimicrobial Peptides: Bacitracin; Nisin; Magainins; Protegrins; Bacillocins
  • 3) By Animal Antimicrobial Peptides: Cathelicidins; Defensins; Histatins; Lactoferrin; Cationic Antimicrobial Peptides (CAMPs)
  • 4) By Insect Antimicrobial Peptides: Cecropins; Defensins; Attacins; Diptericins; Melittin
  • Companies Mentioned: Wuxi AppTec; Sigma Aldrich Chemicals Private Limited; Ipsen S.A.; Novozymes A/S; GenScript Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti Microbial Peptides Market Characteristics

3. Anti Microbial Peptides Market Trends And Strategies

4. Anti Microbial Peptides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anti Microbial Peptides Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Anti Microbial Peptides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Anti Microbial Peptides Market Growth Rate Analysis
  • 5.4. Global Anti Microbial Peptides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Anti Microbial Peptides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Anti Microbial Peptides Total Addressable Market (TAM)

6. Anti Microbial Peptides Market Segmentation

  • 6.1. Global Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant Antimicrobial Peptides
  • Bacterial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
  • Insect Antimicrobial Peptides
  • 6.2. Global Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pneumonia
  • Hepatitis
  • Bacterial infections
  • Human Immunodeficiency Viruses
  • 6.3. Global Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical
  • Subcutaneous
  • Intravenous
  • 6.4. Global Anti Microbial Peptides Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Research Institutes
  • Specialty Clinic
  • Pharmacies
  • 6.5. Global Anti Microbial Peptides Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Healthcare
  • Agriculture Industry
  • Biological Engineering
  • 6.6. Global Anti Microbial Peptides Market, Sub-Segmentation Of Plant Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Defensins
  • Thionins
  • Hevein-Like Peptides
  • Plant Defensin-Like Peptides
  • Lipid Transfer Proteins (LTPs)
  • 6.7. Global Anti Microbial Peptides Market, Sub-Segmentation Of Bacterial Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacitracin
  • Nisin
  • Magainins
  • Protegrins
  • Bacillocins
  • 6.8. Global Anti Microbial Peptides Market, Sub-Segmentation Of Animal Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cathelicidins
  • Defensins
  • Histatins
  • Lactoferrin
  • Cationic Antimicrobial Peptides (CAMPs)
  • 6.9. Global Anti Microbial Peptides Market, Sub-Segmentation Of Insect Antimicrobial Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cecropins
  • Defensins
  • Attacins
  • Diptericins
  • Melittin

7. Anti Microbial Peptides Market Regional And Country Analysis

  • 7.1. Global Anti Microbial Peptides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Anti Microbial Peptides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti Microbial Peptides Market

  • 8.1. Asia-Pacific Anti Microbial Peptides Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti Microbial Peptides Market

  • 9.1. China Anti Microbial Peptides Market Overview
  • 9.2. China Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti Microbial Peptides Market

  • 10.1. India Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti Microbial Peptides Market

  • 11.1. Japan Anti Microbial Peptides Market Overview
  • 11.2. Japan Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti Microbial Peptides Market

  • 12.1. Australia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti Microbial Peptides Market

  • 13.1. Indonesia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti Microbial Peptides Market

  • 14.1. South Korea Anti Microbial Peptides Market Overview
  • 14.2. South Korea Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti Microbial Peptides Market

  • 15.1. Western Europe Anti Microbial Peptides Market Overview
  • 15.2. Western Europe Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti Microbial Peptides Market

  • 16.1. UK Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti Microbial Peptides Market

  • 17.1. Germany Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti Microbial Peptides Market

  • 18.1. France Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti Microbial Peptides Market

  • 19.1. Italy Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti Microbial Peptides Market

  • 20.1. Spain Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti Microbial Peptides Market

  • 21.1. Eastern Europe Anti Microbial Peptides Market Overview
  • 21.2. Eastern Europe Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti Microbial Peptides Market

  • 22.1. Russia Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti Microbial Peptides Market

  • 23.1. North America Anti Microbial Peptides Market Overview
  • 23.2. North America Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti Microbial Peptides Market

  • 24.1. USA Anti Microbial Peptides Market Overview
  • 24.2. USA Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti Microbial Peptides Market

  • 25.1. Canada Anti Microbial Peptides Market Overview
  • 25.2. Canada Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti Microbial Peptides Market

  • 26.1. South America Anti Microbial Peptides Market Overview
  • 26.2. South America Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti Microbial Peptides Market

  • 27.1. Brazil Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti Microbial Peptides Market

  • 28.1. Middle East Anti Microbial Peptides Market Overview
  • 28.2. Middle East Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti Microbial Peptides Market

  • 29.1. Africa Anti Microbial Peptides Market Overview
  • 29.2. Africa Anti Microbial Peptides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Anti Microbial Peptides Market, Segmentation By Ailments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Anti Microbial Peptides Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti Microbial Peptides Market Competitive Landscape And Company Profiles

  • 30.1. Anti Microbial Peptides Market Competitive Landscape
  • 30.2. Anti Microbial Peptides Market Company Profiles
    • 30.2.1. Wuxi AppTec Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sigma Aldrich Chemicals Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Ipsen S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GenScript Biotech Overview, Products and Services, Strategy and Financial Analysis

31. Anti Microbial Peptides Market Other Major And Innovative Companies

  • 31.1. Bachem Holding AG
  • 31.2. Basilea Pharmaceutica Ltd.
  • 31.3. Probiotec Limited
  • 31.4. Migenix Inc.
  • 31.5. Zymeworks Inc.
  • 31.6. Venatorx Pharmaceuticals Inc.
  • 31.7. AMPS Biotech Pvt. Ltd.
  • 31.8. AnaSpec Inc.
  • 31.9. MediGene AG
  • 31.10. Hycult Biotech
  • 31.11. Phoenix Biotechnology Inc.
  • 31.12. Shenzhen Sunsmile Biotechnology Co. Ltd.
  • 31.13. WatsonBio Sciences
  • 31.14. Helix BioMedix
  • 31.15. Jiangsu ProteLight Pharmaceutical and Biotechnology Co. Ltd.

32. Global Anti Microbial Peptides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti Microbial Peptides Market

34. Recent Developments In The Anti Microbial Peptides Market

35. Anti Microbial Peptides Market High Potential Countries, Segments and Strategies

  • 35.1 Anti Microbial Peptides Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Anti Microbial Peptides Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Anti Microbial Peptides Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33395_Anti_Microbial_Peptides_GMR_2025